Nominations are called from financial members of the Australasian Diabetes in Pregnancy Society Limited (ADIPS Ltd) for the ADIPS Board of Directors (formerly the Council) as outlined by item 11 of the Constitution (click here for extract) to hold office from 19 November 2022. Nominations must be signed by the proposer, seconder and the nominee who must ALL be current financial members of ADIPS Ltd. There will be three vacant positions on the Board of Directors.
Nominations must reach the ADIPS Company Secretary by midnight on Monday 29 August 2022. The completed nomination form must be emailed to email@example.com.
Three positions on the Board of Directors will become vacant at the Annual General Meeting to be held at the Sheraton Grand Hyde Park Hotel, Sydney on 19 November 2022. If more than three eligible nominations are received, there will be a ballot whereby the membership of ADIPS Ltd will vote. The successful nominees will become directors of the Society which is a Company Limited by Guarantee and is registered with the Australian Securities and Investments Commission (ASIC). Please familiarise yourself with the responsibilities that come with being a director of a Public Company prior to submitting your nomination by reading the relevant information on the ASIC website or use this link https://asic.gov.au/for-business/running-a-company/company-officeholder-duties/your-company-and-the-law/.
The following directors will continue on the Board: Professor David Simmons (Endocrinologist, NSW), Dr Arianne Sweeting (Endocrinologist, NSW), A/Prof Alexis Shub (Obstetrician and MFM Specialist, VIC), Ms Julia Zinga (Dietitian, VIC), Dr Rosemary Hall (Endocrinologist, Wellington, New Zealand), A/Prof Susan de Jersey PhD (Advanced Dietitian, QLD).
Retiring from the Board are Dr Victoria Rudland (Endocrinologist, NSW), Ms Janet Lagstrom (Nurse Practitioner/CDE, VIC), Dr Sarah Price (Endocrinologist, VIC) and Ms Marina Mickleson (Nurse Practitioner/CDE, WA).